NKGen presents new data on NK cell therapy targeting dementia
NKGen presented new clinical data on troculeucel’s potential in Alzheimer’s, Parkinson’s and frontotemporal dementia. NKGen Biotech had a slot at a biologics conference in Incheon last week, and the subject was dementia, not cancer, which is a little odd since NKGen actually built its business on ca
<p>NKGen presented new clinical data on troculeucel’s potential in Alzheimer’s, Parkinson’s and frontotemporal dementia. NKGen Biotech had a slot at a biologics conference in Incheon last week, and the subject was dementia, not cancer, which is a little odd since NKGen actually built its business on ca</p>